1. Introduction {#s0005}
===============

Previous studies have shown that the exposure to particulate matter (PM) is associated with increased morbidity and mortality, primarily from cardiovascular disease (CVD) ([@bib18]; [@bib42]; [@bib44]; [@bib50]; [@bib56]). To date, the underlying molecular mechanism responsible for this consistently observed association between air pollution and CVD risk is still poorly understood. It has been proposed that ambient particles might trigger pulmonary oxidative stress and inflammatory responses, leading to the release of molecular signals into the circulatory system ([@bib11]).

Several investigators have hypothesized that oxidative stress directly induced in the lungs after PM inhalation ([@bib48]), might cause a systemic inflammatory cascade, increasing cardiovascular risk among susceptible individuals ([@bib4]; [@bib22]; [@bib57]).

Obesity may increase susceptibility to PM~10~ exposure, exacerbating its effects on cardiovascular disease ([@bib45]) and on biomarkers of vascular inflammation ([@bib38]); in fact, it has been suggested that obese subjects inhale more air-per-day than normal-weight individuals ([@bib13], [@bib58]), thus potentially increasing their overall dose ([@bib56]). Recent studies have further demonstrated that populations characterized by a high body mass index (BMI), when compared to normal weight populations, exhibit an increased risk of CVDs, due to a higher exposure to air pollutants ([@bib16], [@bib26]; [@bib30])

The biological mechanisms behind these associations have not been fully elucidated yet, but many of the obesity-related diseases are thought to be linked to a state of chronic oxidative stress and inflammation. Obese subjects have indeed increased systemic oxidative stress and impaired oxidant defense ([@bib20], [@bib32], [@bib38], [@bib46]).

To try to improve our understanding on the role of obesity as a susceptibility factor, we designed an epidemiological study where we investigated the effects of PM~10~ on blood DNA methylation in a population of 186 overweight/obese subjects ([@bib55]).

DNA methylation has been shown to regulate biological processes underlying CVDs, such as inflammation and immune response. ([@bib2], [@bib3]) By regulating inflammatory pathways, that are key elements in the onset of CVDs, pro-inflammatory gene methylation might be related to cardiovascular health ([@bib1]).

In detail, we measured DNA methylation in a set of candidate genes, including of CD14, TLR4 and TNF-α ([@bib9]), selected for the important roles that they play in the inflammatory pathway. CD14 is a pattern recognition receptor in the innate immune response against microorganisms and other exogenous and endogenous stress factors. The most important CD14 signaling co-receptor is TLR4, required to trigger the downstream signaling pathways that lead to the activation of the nuclear factor κB (NF-кB) inflammatory pathway that in turn promotes the increase in pro-inflammatory cytokine production including tumor necrosis factor (TNF) ([@bib5]; [@bib19]; [@bib25]). In addition CD14/TLR4 are over-expressed in obese subjects, reflecting a state of low-grade chronic inflammation ([@bib21], [@bib25]).

2. Materials and methods {#s0010}
========================

2.1. Study subjects {#s0015}
-------------------

Overweight/obese subjects were recruited at the Center for Obesity and Work (Department of Preventive Medicine, IRCCS Fondazione Ca'Granda -- Ospedale Maggiore Policlinico) in the period between September 2010 and April 2011. These subjects were the first 186 subjects consecutively enrolled in the context of the larger study SPHERE (ERC-2011-StG 282413), ([@bib10]) which was aimed at examining the possible molecular mechanisms underlying the effects of PM exposure in relation to health. Each participant signed a written informed consent, approved by the Ethic Committee of the Fondazione Ca'Granda -- Ospedale Maggiore Policlinico (Approval no. 1425), in accordance with the Helsinki Declaration principles.

All subjects willing to participate in the study had to unchanged body weight and constant dietary habits in the last year. In addition, they had constant physical activity for at least one month before entry into the study. Exclusion criteria was the presence of a major disease such as cancer, autoimmune disease, cardiovascular disease.

Subjects who agreed to participate were asked to complete lifestyle and dietary questionnaires and to donate a blood sample. Information about lifestyle factors, including current and past smoking habits, alcohol consumption and physical activity, were collected with a self-administered questionnaire.

Body mass index (BMI) was calculated as the ratio between the subject's weight (kg) and height squared (m^2^). According to the current definition ([@bib59]) , subjects who had a BMI ranging from 25 to 29.9 were classified as overweight, and subjects who had a BMI of 30 or higher were classified as obese.

Waist circumference (cm) was also assessed as marker of central fat accumulation. Fasting level of total cholesterol was measured from serum samples by routine methods (Modular, Roche- Basel, Switzerland). Blood pressure was measured with the participant supine, after 5 min of rest.

2.2. Assessment of PM~10~ exposure {#s0020}
----------------------------------

PM~10~ concentrations were assigned to each participant\'s residential address from September 1, 2010 to April 11, 2011. The PM~10~ concentrations were recorded by the Regional Environmental Protection Agency (ARPA Lombardia) through monitoring stations located throughout Lombardy and available online as daily means. To assign a PM~10~ exposure level to each subject, the addresses of the monitoring stations and the study subjects were geocoded and the PM~10~ measured from the nearest monitor to residential address was assigned. For each subject, we used the daily mean of PM~10~ concentrations measured 1 day before the date of recruitment and back to 14 days before enrollment,. In case of incomplete series, each missing value was imputed by using an algorithm that integrates the annual average of the incomplete series and the PM~10~ concentrations of the nearest and more correlated monitors ([@bib15]).

2.3. Sample collection, DNA extraction and bisulfite treatment {#s0025}
--------------------------------------------------------------

Seven milliliters of whole blood were collected into EDTA tubes from each participant by venous phlebotomy. Blood was centrifuged at 2500 rpm for 15 min. The buffy coat fraction was transferred to a cryovial and immediately frozen at −80 °C until use. DNA was extracted by the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA), according to the manufacturer's instructions.

500 ng of genomic DNA was treated with the EZ DNA Methylation-Gold™ Kit (Zymo Research, Orange, CA, USA), in accordance with the manufacturer's protocol. Bisulfite-treated DNA was eluted in 30 μL of M-Elution Buffer and kept at −80 °C until use.

2.4. DNA Methylation {#s0030}
--------------------

Analysis of DNA methylation was performed by previously published methods ([@bib8], [@bib51]), with minor modifications. Briefly, a 50-μL PCR reaction was carried out with 25 μL of Hot Start GoTaq Green Master mix (Promega), 1 pmol of forward primer, 1 pmol of biotinylated reverse primer and 25 ng of bisulfite-treated genomic DNA. Biotin-labeled primers were used to purify the final PCR product with Sepharose beads. The PCR product was bound to a Streptavidin Sepharose HP (Amersham Biosciences, Uppsala, Sweden). Sepharose beads containing the immobilized PCR product were purified, washed, denatured with 0.2 M NaOH and washed again with the Pyrosequencing Vacuum Prep Tool (Pyrosequencing, Inc., Westborough, MA, USA), according to the manufacturer's instructions. Pyrosequencing primer (0.3 µm) was annealed to the purified single-stranded PCR product, and pyrosequencing was performed with the PyroMark MD System (Pyrosequencing, Inc. Westborough, MA, USA). PCR cycling conditions and primer sequences are reported in [Table 1](#t0005){ref-type="table"}. The methylation level at CpG positions within each gene's promoter region, was expressed as the percentage of cytosines that were methylated, determined as the number of methylated cytosines divided by the sum of methylated and unmethylated cytosines, multiplied by 100% (% 5-methyl-Cytosine). Every sample was tested two times for each marker to confirm reproducibility and to increase the precision of the findings.

Intra-observer coefficient of variability between the two replicates of DNA methylation measurements was 7.9% (SD=9.1%) for CD14, 3% (SD=2.7%) for TLR4 and 5% (SD=5.1%) for TNF-α.

2.5. Statistical analysis {#s0035}
-------------------------

DNA methylation values exhibited non-normal distribution, and were thus log-transformed. We expressed them as variations in term of Z-score for each gene, in order to standardize values according to the population's mean and standard deviation. DNA methylation measurements for each subject were performed for four CpG dinucleotide positions replicated in two measurements. To consider intra-individual correlation due to repeated-measure data structure we designed linear mixed models. The CpG dinucleotide position was considered introducing a random effect model. The intra-observer coefficient of variability between the two replicate of DNA methylation was measured using the mean of the four positions for each gene.

We then evaluated the association of daily mean concentration of PM~10~ with specific methylation.

DNA methylation Z-scores were modelled both as singles genes and as a pathway which identifies a common inflammatory system pathway. Methylation gene Z-scores for multiple genes within the pathway were modelled as a vector of 24 responses within each sample (i.e., three genes measured on each sample; each sample measured at four positions in two runs) as a function of PM~10~ concentrations and other selected covariates. Mixed effect models allowed us to analyze each gene separately while taking into account differences between the three genes within the pathway, and simultaneously adjusting for the correlation between the repeated measured on a single subject. Scaled regression coefficients were used to represent the increase in DNA methylation estimated for a 1-SD increment in the independent variable.

Daily mean PM~10~ concentrations were considered both as continuous measures, assuming linearity of the relationship pollutant-gene, and as categorized into quartiles. We reported beta regression coefficient (β) expressing: a) the logarithmic change in target methylation Z-scores associated with a standard deviation increase in PM~10~ concentration level; b) the logarithmic change in methylation Z-scores associated with change in PM~10~ switching from the first quartile to the others, in the context of quartile model approach. We used the fitted mixed effect model to calculate the predicted mean Z-score and standard errors for each quartile of PM~10~ exposure, in order to show dose-response relationships. All models were adjusted for covariates that were selected a priori: body mass index, age (years), sex, percentage of neutrophils, smoking habits (never smokers, ex-smokers actual smokers), position, run, batch, interaction terms among position, run and batch. Pathway model was also adjusted for singles methylation genes. The role of further possible covariates (diabetes lymphocytes, physical activity, week, season, apparent temperature) was checked by univariate analyses, but none of the them resulted significantly associated with DNA methylation. We finally checked the possible modification of PM~10~ effect on DNA methylation testing the interaction between PM and BMI and in case of significance we stratified subjects according to their BMI level. A p-value of 0.05 was considered as statistically significant. All analyses were performed by SAS 9.3 (SAS Institute Inc., Cary, NC, USA).

3. Results {#s0040}
==========

Subjects included in our study were a subset of the SPHERE participants, whose characteristics have been detailed in previous works . ([@bib9], [@bib10]) The study subjects were predominantly female (80% of the population), 122 were obese (66%) and 64 were overweight (34%), with a mean age of 51 years.

51% of the subjects had never smoked, 30% were former smokers and approximately 16% were current smokers; mean value of BMI was 33.4±6 kg/cm^2^ and of total cholesterol was 217.8±41.8 mg/dl ([Table 2](#t0010){ref-type="table"}).

[Table 3](#t0015){ref-type="table"} shows the mean daily levels of the individual PM~10~ values attributed to each study subject and evaluated within 1  day to 14 days before the subject recruitment: PM~10~ averaged from 48.0 (2 days before recruitment) to 54.8 ng/m^3^ (4 and 13 days before recruitment).

The mean methylation levels (%5mC) of CD14, TLR4 and TNF-α genes are reported in [Table 4](#t0020){ref-type="table"}, together with the %5mC values for the log-transformed genes and their corresponding Z-scores. Results of the models estimating the association of the PM~10~ exposure as a continuous measure with single methylation genes, grouped by inflammatory pathway, are shown in [Table 5](#t0025){ref-type="table"}. From the evaluation of the linear association of the PM~10~ exposure with the single gene methylation, we found that CD14 was associated with PM~10~ exposure between 4 and 6 days before recruitment, (P~4days~=0.029; P~5days~=0.028; P~6days~=0.006). TLR4 was associated with the PM~10~ exposure between 6 and 8 days before recruitment (P~6days~=0.048; P~7days~=0.006; P~7days~=0.059), while no significant association was observed with TNF-α ([Table 5](#t0025){ref-type="table"}).

When we jointly analyzed the three genes as a whole pathway, we found a significant association between the daily mean PM~10~ concentration measured six days before recruitment (P=0.019) and the inflammatory pathway.

In order to assess whether the BMI could influence the relationship between the PM10 and singles DNA methylation genes, we tested with a sensitivity analysis the interaction between the BMI and the PM10 exposure. We noticed that the BMI levels seem not to affect differentially the relationship between PM10 and each single methylation gene level but they have differential effects on the inflammatory gene pathway. In the analysis stratified according to three levels of BMI (25≤BMI\<30; 30≤BMI\<35; BMI≥35) the effect of PM10 on reducing the methylation of the inflammatory pathway was confirmed in the subgroup of overweight patients (β25≤BMI\<30=−0.191,P\<0.001), but not in the subgroup of obese (β30≤BMI\<35=0.012; P=0.856) and severely obese patients (βBMI≥35=−0.030; P=0.910).

In the quartile model approach, focusing on the 6 days before recruitment , we observed differences in the levels of methylation genes across quartiles of exposure for the CD14 gene (P=0.003) and for the inflammatory pathway (P=0.023). ([Table 6](#t0030){ref-type="table"}; [Fig. 1](#f0005){ref-type="fig"}).

4. Discussion {#s0045}
=============

Our results describe an inverse association between measured level of daily PM~10~ exposure and DNA methylation of inflammatory genes, assessed in peripheral blood of overweight/obese subjects.

The effect was maximum for the exposure of 6 days before recruitment, and spanned from day 4 to day 8. In particular, the association between PM~10~ and CD14 methylation was observed in days 4--5-6, between PM~10~ and TLR4 methylation in days 6--7-8. TNF-α methylation was not associated to PM~10~.

Numerous recent studies about the pathogenesis of different types of diseases have reported associations between PM exposure and alterations in DNA methylation. Investigated outcomes include cardiovascular and respiratory disease, lung cancer, type 2 diabetes, and diseases of the central nervous system (Alzheimer's and Parkinson's diseases) ([@bib24]). The pathogenic process of most diseases begins with the inflammatory cascade. In this study we analyzed candidate genes involved in the inflammatory pathway, regulated by DNA methylation and whose individual alterations were associated to PM exposure ([@bib7], [@bib29], [@bib35]).

The inflammation cytokine CD14 is mainly produced by monocytes ([@bib36]) and it performs as a component of the innate immune system ([@bib53]). CD14 plays a key role in the process of inflammation as it is the receptor of lipopolysaccharide (LPS), a cytoderm ingredient of gram-negative bacteria, with which it could combine and lead to the cell activation and the release of the pro-inflammatory cytokines ([@bib41]). The expression levels of CD14 can be modulated by epigenetic factors, especially DNA methylation ([@bib14], [@bib40], [@bib47]).

TLR4, along with the CD14 receptor, is associated with the recognition of LPS and the activation of the immune response ([@bib52]). In a recent study Kim T.W. et al. suggest that the expression of TLR4 is suppressed due to epigenetic events such as methylation of DNA ([@bib33], [@bib49]).

TNF-α is a highly pleiotropic cytokine ([@bib12], [@bib43]) produced by macrophages/monocytes during acute inflammation ([@bib54]) playing a critical role in the pathogenesis of chronic inflammatory diseases along with cell proliferation, differentiation, necrosis and apoptosis ([@bib37]). TNF-α promoter methylation has also been related to the adipogenesis process ([@bib64]) and to age-related inflammatory diseases ([@bib23]).

Our findings, taken together, may reflect the biological mechanism underlying the beginning of the inflammatory cascade. CD14 could represent a key actor of the inflammatory pathway because it is essential in the activation of TLR4 which, in turn, triggers NF-кB, the central element in the PM-induced inflammatory pathway promoting the cytokines cascade ([@bib17], [@bib62]). Taking into account this biological consideration, we could explain the time-line of the observed associations: CD14 was associated with the level of PM~10~ recorded 4--6 days before the blood drawing, TLR4 was associated with PM~10~ level recorded 6--8 days before, whereas the genes grouped in the inflammatory pathway showed an association 6 days before.

Although in literature it is widely recognized that PM exposure is associated to an increase of gene expression of cytokines, such as TNF-α ([@bib39], [@bib61], [@bib63]), in our study we didn't find any association between TNF-α, methylation and PM~10~ exposure. It is plausible that, in the regulation of TNF-α expression, it may be involved either a pre-transcriptional regulation, such as other epigenetic markers (e.g. histone modifications), or post-transcriptional mechanisms (e.g. microRNAs). Future investigations regarding other possible regulation markers are needed in order to better understand biological events linking PM exposure to TNF-α gene expression.

Epidemiological studies have shown that obesity may confer greater susceptibility to the adverse effects of PM exposure, since adipocytes have increased particle accumulation ([@bib10]; [@bib22]) A positive correlation between exhaled nitric oxide, a marker of pulmonary inflammation, and BMI has been shown in healthy adults ([@bib60]) Moreover, a differential autonomic cardiac response (measured as heart rate variability) to metal particles has been observed between obese and non-obese individuals ([@bib16]). Obesity represents a pro-inflammatory state ([@bib28], [@bib31]) which itself may increase susceptibility to air pollution by increasing the response to inflammatory stimuli.

Our study was based on a population of overweight/obese subjects recruited at the Center for Obesity and Work and it did not include any normal weight subjects. Notably, this population is characterized by a higher BMI than the Italian average one. Hence, the study group may be quite different from the general population, and these differences could inhibit the generalization of our findings. Although the prevalence of overweight/obese males is higher than the prevalence of overweight/obese females in the general population, our study group included a higher proportion of overweight/obese women. One possible explanation is that women are, in general, more concerned about their appearance than men, so they may be more likely to seek out personalized diet protocols and diet centers that provide periodic medical checks ([@bib9]).

Because of the limited number of study subjects, it is possible that the associations observed were due to chance. However, we controlled for several potential confounders by fitting multivariable models that included several individual characteristics as independent variables, in order to provide a good setting for evaluating mechanistic questions and reduce bias and chance findings.

The methylation analyses were performed on white blood cell DNA. Blood leukocytes include several cell type subsets and data from previous DNA methylation studies have suggested that small differences in DNA methylation in blood may be localized in a cell subtype with a specific immune or inflammatory function ([@bib34], [@bib51], [@bib65]). In this work, further analysis showed that the addition in multivariable regression models of percent monocytes and lymphocytes did not modify the associations of DNA methylation of CD14, TLR4 and TNF-α. However, since we used unfractionated leukocytes, we cannot determine which leukocyte subtypes were sensitive to the effects of the exposure on DNA methylation. Since white blood cells regulate the systemic response to inflammation, which is the biological key mechanism in the relation we examined, the measurements of DNA methylation of CD14, TLR4 and TNF-α in white blood cells may be appropriate. We also noticed that the effects observed in blood leukocytes cannot be extended to other relevant cell types, such as endothelia and other vascular tissues. Further researches are needed to identify the effects of PM on specific isolated leukocyte subtypes.

Our statistical approach modelled the overall DNA methylation over multiple CpG sites measured in each of the three genes we evaluated. In addition, our data showed a high correlation among individual CpG sites of each gene. This approach is consistent with a recent study regarding the correlation of methylation states between adjacent CpG sites, which showed that the methylation status at adjacent CpG sites tends to be correlated and may act in concert to control gene expression ([@bib6], [@bib27]).

It is difficult to draw conclusions with a limited set of gene targets per pathway. These targets and their relationships with PM should be pursued by including additional gene targets and posttranscriptional markers.

In conclusion, our findings confirm the relationship among PM exposure, obesity and transcriptional regulation of inflammatory gene pathway, even though it will be required to include a larger number of genes targets for inflammatory pathway, in future studies.

Human subjects {#s0050}
==============

This research project was approved by the 'Maggiore Policlinico Hospital, Mangiagalli and Regina Elena Foundation' Institutional Review Board and the participants gave their informed consent.

This study was supported by the EU Programme "Ideas" (ERC-2011-StG 282413, to Valentina Bollati).

We wish to thank the Occupational Medicine Medical Residents for their help in examining and recruiting the study subjects. We are grateful to the nurses of the "Medicina del Lavoro" Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, the nutritionist Daniela Sommaruga, Elisabetta Angiolino from Regional Environmental Protection Agency (ARPA), as well as the volunteers who participated in the study.

![Quantile plot of estimated Z-score (±SD) of gene-specific DNA methylation and inflammatory pathway in relation to exposure to PM~10~ six days before withdrawal, depicts a significant association between PM~10~ quartiles and CD14 methylation gene (P=0.003) and inflammatory pathway (P=0.023) and a significant different slopes of the among genes in relation to exposure to PM~10~ quartiles the sixth day before withdrawal(P\<0.001).](gr1){#f0005}

###### 

Pyrosequencing assays information.

Table 1

  **Gene**    **Chromosome**                      **CpG position**[a](#tbl1fna){ref-type="table-fn"}   **Primers: Forward (F), Reverse (R) and Sequencing (S)**
  ----------- ----------------------------------- ---------------------------------------------------- ----------------------------------------------------------
  **CD14**    5                                   140632047                                            **F**:GGGTTTATAGAGGAGGGAATTGA
  140632043   **R**:Biotin-AAACCCCATCCAACCCCTAT                                                        
  140632041   **S**:TGTAGGGTTTTGGGG                                                                    
  140632031                                                                                            
                                                                                                       
  **TLR4**    9                                   117704398                                            **F**: Biotin-AGGAAGAGAAGATATTAGTGTTTT
  117704406   **R**: CCTAACATCATCCTCACTACTTCT                                                          
  117704415   **S**: ACAACAATAACCCTATAAAT                                                              
                                                  117704422                                            
                                                                                                       
  **TNF-α**   6                                   2874672                                              **F**:Biotin-TGAGGGGTATTTTTGATGTTTGT
  2874678     **R**: TTAATAATTATTTTTATATATTTT                                                          
  2874680     **S:** ATAAATTTTATATTTTTTAT                                                              
                                                  2874695                                              

According to UCSC Genome Browser ([https://genome.ucsc.edu/](http://https://genome.ucsc.edu/){#ir0005}), Dec 2013 release (GRch38/hg38).

###### 

Baseline subjects characteristics.

Table 2

  **Characteristics of subjects**       **N**   
  ------------------------------------- ------- --------------
  Age, *Years*                          186     50.7 ± 11.7
  Sex, *n*(%)                                   
   Male                                         37 (20.0%)
   Female                                       149 (80.0%)
  BMI, kg/cm^2^                         186     33.4 ± 6.0
   Overweight (25≤BMI\<30) )                    64 (34.4)
   Class I obesity (30≤BMI\<35)                 60 (32.3)
   Class II-III obesity (BMI≥35)                62 (33.3.)
  Waist circumference, *cm*             183     99.9 ± 13.3
  Smoking, *n*(%)                               
   Never smoker                                 95 (51.1%)
   Ex-smoker                                    56 (30.1%)
   Actual smoker                                29 (15.6%)
   Missing                                      6 (3.2%)
  Percentage of neutrophils             186     58.8 ± 7.9
  Total Cholesterol, mg/dl              183     217.8 ± 41.8
  Diabetes, *n*(%)                              
   Yes                                          18 (9.7%)
   No                                           148 (79.6%)
   Missing                                      20 (10.8%)
  Hypertension, *n*(%)                          
   Yes                                          53 (28.5%)
   No                                           116 (62.4%)
   Missing                                      17 (9.1%)
  Physical Activity Frequency, *n*(%)           
   Never                                        98 (52.7%)
   \< 2 times a week                            28 (15.1%)
   2--4 times a week                            20 (10.8%)
   \> 4 times a week                            22 (10.8.%)
   Missing                                      18 (9.7%)

Continuous variables are expressed as mean±SD, categorical variables are expressed as absolute numbers and frequencies.

###### 

Distribution of the daily mean levels of ambient particulate matter ≤10 µm in aerodynamic diameter (PM~10~), within 1  day to 14 days before recruitment\'.

Table 3

  **Days before recruitment**   **Mean (µg/m**^**3**^**)**   **SD**   **Quartiles (µg/m**^**3**^**)**                     
  ----------------------------- ---------------------------- -------- --------------------------------- -------- -------- -------
  1 day                         49.1                         32.6     ≤24                               25--39   40--69   \>154
  2 days                        48.0                         31.6     ≤26                               27--42   43--64   \>163
  3 days                        51.3                         33.2     ≤28                               29--45   46--67   \>174
  4 days                        54.8                         34.3     ≤28                               29--48   49--70   \>174
  5 days                        53.9                         30.2     ≤31                               32--47   48--68   \>145
  6 days                        53.3                         29.1     ≤33                               34--46   47--70   \>157
  7 days                        54.1                         33.2     ≤30                               31--45   46--67   \>174
  8 days                        51.5                         33.6     ≤27                               28--42   43--68   \>159
  9 days                        48.6                         31.1     ≤26                               27--40   41--66   \>157
  10 days                       49.9                         32.6     ≤27                               28--42   43--64   \>174
  11 days                       53.4                         29.7     ≤31                               32--51   52--70   \>157
  12 days                       54.6                         30.5     ≤32                               33--48   49--70   \>164
  13 days                       54.8                         30.7     ≤31                               32--45   46--71   \>157
  14 days                       52.4                         34.6     ≤26                               27--40   41--72   \>157

Values in table are mean, standard deviation (SD) and 1th to 4th quartiles of daily means levels of the individual values attributed to each study subject.

###### 

Mean values of genes, log-transformed genes and their corresponding Z-scores grouped by common inflammatory pathway.

Table 4

  **Measures**               **Methylation genes (%5mC)**               
  -------------------------- ------------------------------ ----------- ------------
  Inflammatory pathway                                                  
  Mean±SD                    3.82±1.98                      4.58±1.43   11.41±5.36
  Mean±SD, log transformed   1.26±0.39                      1.47±0.32   2.32±0.51
  Mean Z-score±SD            −0.01±1.01                     0.01±0.99   −0.01±1.01

###### 

Association between PM~10~ exposures, singles methylation genes and genes grouped by common inflammatory pathway.

Table 5

  Exposure to PM~10~ before recruitment   β-coefficient[a](#tbl5fna){ref-type="table-fn"} (SE), p-values                                                                              
  --------------------------------------- ---------------------------------------------------------------- ------- ---------------- ------- ---------------- ------- ---------------- -------
  1 day                                   −0.030 (0.056)                                                   0.591   −0.156 (0.088)   0.080   0.015 (0.035)    0.673   −0.002 (0.032)   0.942
  2 days                                  −0.061 (0.055)                                                   0.269   0.048 (0.083)    0.570   0.002 (0.035)    0.957   0.007 (0.032)    0.833
  3 days                                  −0.091 (0.054)                                                   0.093   0.041 (0.078)    0.599   0.015 (0.034)    0.670   −0.006 (0.032)   0.848
  4 days                                  −0.120 (0.054)                                                   0.029   −0.017 (0.085)   0.839   −0.034 (0.035)   0.327   −0.052 (0.032)   0.109
  5 days                                  −0.120 (0.054)                                                   0.028   0.011 (0.096)    0.905   −0.047 (0.035)   0.180   −0.047 (0.032)   0.149
  6 days                                  −0.155 (0.056)                                                   0.006   −0.169 (0.084)   0.048   −0.011 (0.036)   0.768   −0.075 (0.032)   0.019
  7 days                                  −0.041 (0.055)                                                   0.453   −0.260 (0.093)   0.006   −0.004 (0.036)   0.918   −0.035 (0.032)   0.279
  8 days                                  0.047 (0.055)                                                    0.400   −0.187 (0.098)   0.059   −0.005 (0.036)   0.902   0.014 (0.033)    0.677
  9 days                                  0.018 (0.054)                                                    0.741   −0.060 (0.091)   0.511   0.017 (0.036)    0.640   0.018 (0.033)    0.580
  10 days                                 0.051 (0.056)                                                    0.365   0.012 (0.088)    0.890   −0.011 (0.037)   0.768   0.043 (0.034)    0.204
  11 days                                 0.002 (0.056)                                                    0.972   −0.020 (0.075)   0.787   0.015 (0.035)    0.671   0.011 (0.032)    0.726
  12 days                                 −0.032 (0.057)                                                   0.574   −0.077 (0.079)   0.332   0.019 (0.036)    0.590   −0.011 (0.033)   0.726
  13 days                                 −0.053 (0.059)                                                   0.367   −0.003 (0.102)   0.975   0.016 (0.037)    0.666   −0.005 (0.034)   0.893
  14 days                                 −0.083 (0.057)                                                   0.146   −0.007 (0.108)   0.952   −0.014 (0.036)   0.703   −0.015 (0.034)   0.657

Beta coefficients expressing the logarithmic change in DNA methylation associated with a standard deviation change in PM~10~ level. Models adjusted for: body mass index, age, sex, percentage of neutrophils, smoking habits, position, run, batch, interaction terms among position, run and batch.

Also adjusted for singles methylation genes.

###### 

Association of PM~10~ exposure, the sixth days before recruitment, with singles methylation genes/inflammatory system pathway, using a quartile model approach.

Table 6

  Methylation gene[b](#tbl6fnb){ref-type="table-fn"}     β-coefficient (SE)[a](#tbl6fna){ref-type="table-fn"}                                     
  ------------------------------------------------------ ------------------------------------------------------ ---------------- ---------------- -------
  Exposure to PM~10~ 6 days before                                                                                                                
   CD14                                                  0.047 (0.145)                                          −0.288 (0.153)   −0.441 (0.152)   0.003
   TLR4                                                  0.065 (0.181)                                          0.063 (0.222)    −0.300 (0.231)   0.410
   TNF-α                                                 0.027 (0.094)                                          0.128 (0.1)      −0.017 (0.099)   0.465
                                                                                                                                                  
  *Inflammatory pathway:*                                0.098 (0.084)                                          −0.048 (0.09)    −0.168 (0.089)   0.023
   CD14, TLR4, TNF-α[d](#tbl6fnd){ref-type="table-fn"}                                                                                            

Beta coefficients expressing the logarithmic change in DNA methylation Z-scores associated with change in PM~10~ switching from the first quartile to the others.

Adjusted for: body mass index, age, sex, percentage of neutrophils, smoking habits, position, run, batch, interaction terms among positions, run and batch.

Also adjusted for single methylation genes.

The type 3 test of fixed effects, testing whether there is any difference among the 4 group. Quartile 1 is the referent group.
